Gleiss Lutz advises PHOENIX on the acquisition of McKesson’s European business
A team of Gleiss Lutz lawyers has advised PHOENIX Pharmahandel GmbH & Co KG (“PHOENIX”) on the acquisition of large parts of the Continental European business of US pharmaceutical distributor McKesson Corporation, Irving, Texas (“McKesson”). The transaction covers business operations in Belgium, France, Ireland, Italy, Portugal, Slovenia, the Nether-lands, Lithuania and Monaco. The parties have agreed not to disclose the purchase price. Closing of the transaction is subject to the customary regulatory clearances.
Germany’s largest pharmaceutical wholesaler, PHOENIX is the German subsidiary of PHOENIX Pharma SE, a leading healthcare provider in Europe. The group is part of the Merckle group of companies. In a total of 27 countries, PHOENIX supplies pharmacies, doctors and medical facilities with medicines and healthcare products through more than 161 distribution centres. PHOENIX also operates over 2,800 of its own pharmacies in 14 European countries with its pharmacy brands BENU, APOTEK 1, Rowlands Pharmacy and Help Net.
McKesson is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information solutions. McKesson Europe, headquartered in Stuttgart, is part of the McKesson Group and operates in Europe with around 38,000 employees.
The following team of Gleiss Lutz lawyers advised PHOENIX on the transaction: Dr. Rainer Loges (Partner, Munich), Dr. Martin Schockenhoff (of counsel, Stuttgart, both lead), Dr. Julius Scheifele (Munich), Jan Philipp Mohr (counsel, Hamburg), Dr. Markus Braun (Munich), Friedrich Baumgärtel (Düsseldorf, all M&A), Dr. Johannes Culmann, Dr. Stephanie Lumpp (both counsel, both Corporate, both Stuttgart), Dr. Matthias Karl (partner), Dr. Philipp Pichler (counsel), Dr. Patrick Grüner (counsel), Dr. Lukas Aberle, Alexandra Bruch, Dr. Daniela Drixler, Dr. Juliane Langguth (all Competition/Antitrust, all Stuttgart), Dr. Doris-Maria Schuster (partner, Hamburg), Dr. Frauke Sturm (counsel, Stuttgart), Dr. Matthias Böglmüller (Munich), Dr. Daniela Mayr (Hamburg), Alexandra-Helene Schwager (both Hamburg, all Employment), Dr. Jacob von Andreae (partner, Düsseldorf), Dr. Marco König (partner, Stuttgart), Aylin Hoffs (Düsseldorf), Dr. Oliver Junge (Stuttgart), Christoph Goller (Stuttgart), Matthias Hahn (Düsseldorf), Rafael Müller (Stuttgart, all Public Law), Dr. Matthias Werner (counsel), Dr. Theresa Uhlenhut, Michael Feilke, Sebastian Girschick (all IP/IT, Munich), Simon Clemens Wegmann (Berlin), Dr. Manuel Klar (Munich, both data protection), Dr. Johann Wagner (partner), Dr. Hendrik Marchal (counsel, both Tax, both Hamburg), Dr. Helge Kortz (partner), Dr. Thomas Kulzer (counsel), Jana Pinto Escaleira (all Banking & Finance, all Frankfurt).
Olaf Teichert, Director Corporate Legal, provided in-house advice.
The transaction was notarised by notary Dr. Martin C. Schmidt, Frankfurt.
Gleiss Lutz acted as lead counsel for the transaction and managed the law firms in the various European jurisdictions.
Gleiss Lutz regularly advises companies on transactions in the healthcare and life sciences sector, most recently the family-owned Ritter Group on the sale of the undertaking to US technology group Avantor and Swedish medtech company AddLife on the acquisition of Vision Oph-thalmology Group GmbH.